Target intelligence / Profile preview

Mycotoxins in gastrointestinal lumen

Molecular classification
Fungal secondary metabolites, Xenobiotics, Small molecule toxins, Other
01

Overview

Mycotoxins in the gastrointestinal lumen are toxic secondary metabolites produced by fungi such as Aspergillus, Fusarium, and Penicillium that contaminate food supplies worldwide [WHO, 2018]. Upon ingestion, these toxins interact with the intestinal mucosa, where they can disrupt tight junction proteins, induce oxidative stress, and trigger pro-inflammatory cytokine release, leading to impaired gut barrier function [Ghareeb et al., 2015, Toxins]. Major classes include aflatoxins, which are potent hepatocarcinogens, and trichothecenes like deoxynivalenol, which cause acute gastrointestinal distress [NIH, 2023]. Therapeutic strategies target these toxins within the GI lumen to prevent their systemic absorption and subsequent organ toxicity. This is primarily achieved through the use of adsorbents like activated charcoal or clay minerals that sequester the toxins, or through specific enzymes that biotransform them into non-toxic metabolites [EFSA, 2017].

Other names
Fungal toxinsLuminal mycotoxinsDietary mycotoxinsFoodborne mycotoxins
02

Mechanism of action

Physical adsorption and sequestration to prevent systemic absorption; enzymatic degradation into non-toxic metabolites.

03

Biological functions

Inhibition of protein synthesisDisruption of intestinal barrier integrityInduction of oxidative stressModulation of immune responseOther
04

Disease associations

CancerInflammationInfectionMycotoxicosisHepatocellular carcinomaNephropathyOther
05

Safety considerations

Non-specific adsorption of essential nutrients and vitaminsInterference with the absorption of co-administered medicationsPotential for toxin desorption due to pH changes in the gastrointestinal tract
06

Interacting drugs

Activated charcoal

5 more in the full profile.

07

Biomarkers

Urinary aflatoxin M1Aflatoxin-albumin adductsUrinary deoxynivalenolSphinganine/sphingosine ratio

Beyond the preview

Go deeper on Mycotoxins in gastrointestinal lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycotoxins in gastrointestinal lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call